ERMA Systems Welcomes Israel Aker, PharmD, RPh, Thermo Fisher Scientific to Advisory Board to Strengthen Medical Affairs Strategy

MIAMI--(BUSINESS WIRE)--ERMA Systems, the AI-powered SaaS company transforming how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes, proudly announces the appointment of Israel Aker, PharmD, RPh, to its Advisory Board. A seasoned expert in Medical Affairs with deep experience at leading biopharmaceutical organizations, Dr. Aker brings invaluable insight as ERMA deepens its impact across the Life Sciences ecosystem.

Currently serving as lead of Medical Writing & Promotional Review at the PPD™ clinical research business of Thermo Fisher Scientific, Dr. Aker has spent his career at the intersection of clinical, regulatory, and commercial teams—translating complex medical and scientific information into actionable strategies. At ERMA Systems, he will advise on enhancing the platform’s medical review capabilities, ensuring that the evolving needs of Medical Affairs professionals are at the core of future innovation.

“We are thrilled to welcome Israel to the ERMA Advisory Board,” said Julia Gardner, CEO of ERMA Systems. “His depth of experience in Medical Affairs and his ability to bridge science, compliance, and communication will be instrumental as we expand ERMA’s capabilities to better serve medical reviewers and scientific stakeholders.”

Dr. Aker’s appointment signals ERMA’s continued commitment to building a platform that not only streamlines compliance workflows but also supports the strategic role of Medical Affairs in driving product success and patient impact.

“I’m excited to join ERMA at a time when Medical Affairs teams are playing an increasingly critical role in shaping compliant, impactful content,” said Dr. Aker. “ERMA’s vision aligns perfectly with where the industry is headed—faster, smarter, and more collaborative content review processes.”

About ERMA Systems

ERMA Systems is an AI-powered SaaS company revolutionizing how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes. Its flagship platform, ERMA Evaluate™, streamlines internal review workflows—empowering regulatory, medical, and commercial teams to bring compliant materials to market with greater speed, efficiency, and clarity. ERMA Systems is a 100% AWS-hosted SaaS solution that leverages a robust stack of cloud services to power its advanced, AI-enabled MLR workflow. Using Amazon Textract and Amazon Comprehend Medical, ERMA converts millions of pages of prescribing information, promotional content, and clinical trial documentation into structured, actionable data. With Amazon SageMaker powering model training, experimentation, and deployment, ERMA delivers a scalable, low-latency solution that shortens review cycles, enhances compliance accuracy, and adapts in real-time to customer needs.

To learn more about ERMA Systems and its Advisory Board, please visit www.ermasystems.com.